Sponsors

Government and Philips consortium co-invest in digital pathology and AI to improve cancer care in the UK

Royal Philips has been leading two healthcare innovation projects that will receive government investment as part of major cross-sector collaborations. A joint multimillion-pound investment by government and industry partners, this initiative will fully digitise a number of NHS pathology laboratories, expanding access to innovative digital pathology services in the UK.

The digitisation of pathology services by Philips will accelerate the development of novel artificial intelligence (AI) software to support cancer diagnostics, a key strategic goal of the programme and one which will be led by the NHS and Philips.  Building this digital infrastructure will allow the UK to lead globally in the development and adoption of AI in health, meaning improved patient care through better and faster cancer diagnostics and treatment.

www.philips.co.uk/innovate

Latest Issues

DIA-MHRA Global Summit

Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026

UK NEQAS for Microbiology & Parasitology Annual Scientific Meeting 2026

The Royal National Hotel, 38 – 51 Bedford Way, London, WC1H 0DG
27 November, 2026

UK NEQAS webinar: Epigenetics

Online
1 December, 2026

Weqas Annual POCT Conference 2026

London, Venue - TBC
8-9 December, 2026

UK NEQAS webinar: Fresh Muscle Biopsies

Online
8 December, 2026